News Detail
Cambridge, 2 May 2024: Amid recent concerns over potential rare side effects of the AstraZeneca-Oxford COVID-19 vaccine, the pharmaceutical giant has reaffirmed its dedication to patient safety, while underscoring its overall safety profile.
An AstraZeneca spokesperson......
View Details
Source : ANI
AstraZeneca
Covid vaccine
Covid vaccines
Vaxzevria
Covishield
Thrombosis Thrombocytopenia Syndrome
TTS
Related News
- Cipla gets nod to market Afrezza insulin inhalation powder in India (12-12-2024)
- UK regulator probes anti-depressants safety alerts after suicide link (12-12-2024)
- Haryana Food Department to Crack Down on Fake Protein Supplements After Major Bust (12-12-2024)
- Drug inspector sentenced to 3-yr rigorous imprisonment (12-12-2024)
- 11.12 crore worth of short-shelf life medicines expired due to delayed supply to TNMSC: CAG Report (12-12-2024)
- Ayush Ministry amends D&C Act to add Homoeopathy, Sowa Rigpa books and Pharmacopoeias (12-12-2024)
- Construction of all three bulk drug parks are in progress: Ministry of chemicals (12-12-2024)
- Four-member gang nabbed for selling ‘Mephentermine Sulphate’ injections in Hyderabad (12-12-2024)
- Combining BCL-2 and BTK inhibitors shows promise in chronic lymphocytic leukemia (CLL) (11-12-2024)
- Punjab cop arrests man for narcotic drugs case, gets fined by court (11-12-2024)